milliplex (Luminex)
Luminex is a verified supplier 
Luminex manufactures this product 
99
Structured Review
Luminex
milliplex
Milliplex, supplied by Luminex, used in various techniques. Bioz Stars score: 99/100, based on 22564 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/milliplex/milliplex/custom%40milliplex%4042404438
Average 99 stars, based on 22564 article reviews
Milliplex, supplied by Luminex, used in various techniques. Bioz Stars score: 99/100, based on 22564 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/milliplex/milliplex/custom%40milliplex%4042404438
Average 99 stars, based on 22564 article reviews
milliplex - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Multiplex Assay:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Amplification:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Modification:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Stability:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Sequencing:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Clinical Proteomics:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Analysis:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Enzyme-linked Immunosorbent Assay:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Software:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Cell Culture:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Oligomer Restriction:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Control:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Luminex:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Positron Emission Tomography:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target Serologic Assay:Article Title: Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024–2026) Article Snippet: e acquired using the Bio-Rad CFX Opus 96 system. WHO, World Health Organization. Figure 2 dummy alt text To address the severe target dropout caused by the identified mutations, a modified dual-target |